Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Androulakis

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Reviews in Cardiovascular Medicine|March 29, 2022
The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneysEirini Lioudaki, Jennifer Ruth Joslin, Eirini Trachanatzi, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 6, 2016
Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-AnalysisMohan Palla, Tomo Ando, Emmanuel Androulakis, et al.
Amino Acids|July 1, 2015
Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular diseaseNikolaos Papageorgiou, Emmanuel Androulakis, Spyridon Papaioannou, et al.
Current Pharmaceutical Design|August 18, 2017
Statins in Aortic StenosisKarl Norrington, Emmanuel Androulakis, Evangelos Oikonomou, et al.
Journal of Hypertension|January 7, 2016
White-coat hypertension and cardiovascular events: a meta-analysisAlexandros Briasoulis, Emmanuel Androulakis, Mohan Palla, et al.
Trends in Cardiovascular Medicine|March 8, 2016
Statins and myocardial infarction: Type, dose, and administration time: Does it matter?Nikolaos Papageorgiou, Effimia Zacharia, Alexandros Briasoulis, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Cardiac Imaging and Management of Cardiac Disease in Asymptomatic Renal Transplant Candidates: A Current UpdateEirini Lioudaki, Ariadni Androvitsanea, Ioannis Petrakis, et al.
European Heart Journal. Case Reports|October 1, 2025
Cardiac AL amyloidosis in a veteran endurance athlete with pre-existing apical hypertrophic cardiomyopathy: a case reportEmmanuel Androulakis, Szymon Musiol, Michael Papadakis, et al.
Blood Reviews|June 10, 2011
Fibrinogen and cardiovascular disease: genetics and biomarkersDimitris Tousoulis, Nikolaos Papageorgiou, Emmanuel Androulakis, et al.
Current Pharmaceutical Design|June 6, 2016
The Impact of Antiplatelet Treatment on Endothelial FunctionEmmanuel Androulakis, Karl Norrington, Constantinos Bakogiannis, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Reviews in Cardiovascular Medicine|March 29, 2022
The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneysEirini Lioudaki, Jennifer Ruth Joslin, Eirini Trachanatzi, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 6, 2016
Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-AnalysisMohan Palla, Tomo Ando, Emmanuel Androulakis, et al.
Amino Acids|July 1, 2015
Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular diseaseNikolaos Papageorgiou, Emmanuel Androulakis, Spyridon Papaioannou, et al.
Current Pharmaceutical Design|August 18, 2017
Statins in Aortic StenosisKarl Norrington, Emmanuel Androulakis, Evangelos Oikonomou, et al.
Journal of Hypertension|January 7, 2016
White-coat hypertension and cardiovascular events: a meta-analysisAlexandros Briasoulis, Emmanuel Androulakis, Mohan Palla, et al.
Trends in Cardiovascular Medicine|March 8, 2016
Statins and myocardial infarction: Type, dose, and administration time: Does it matter?Nikolaos Papageorgiou, Effimia Zacharia, Alexandros Briasoulis, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Cardiac Imaging and Management of Cardiac Disease in Asymptomatic Renal Transplant Candidates: A Current UpdateEirini Lioudaki, Ariadni Androvitsanea, Ioannis Petrakis, et al.
European Heart Journal. Case Reports|October 1, 2025
Cardiac AL amyloidosis in a veteran endurance athlete with pre-existing apical hypertrophic cardiomyopathy: a case reportEmmanuel Androulakis, Szymon Musiol, Michael Papadakis, et al.
Blood Reviews|June 10, 2011
Fibrinogen and cardiovascular disease: genetics and biomarkersDimitris Tousoulis, Nikolaos Papageorgiou, Emmanuel Androulakis, et al.
Current Pharmaceutical Design|June 6, 2016
The Impact of Antiplatelet Treatment on Endothelial FunctionEmmanuel Androulakis, Karl Norrington, Constantinos Bakogiannis, et al.
Pageof 8